What measurement means for chlamydia screening
Chlamydia is a sexually transmitted infection. Left untreated over time, chlamydia can damage reproductive organs and cause fertility problems. The screening test for chlamydia is a simple urine sample or vaginal swab, which is then tested in a laboratory. When caught early, chlamydia can easily be cured with antibiotics.
Routine screenings are the best way to find chlamydia at an early stage, if you are sexually active. Chlamydia is spread through anal, vaginal or oral sex. You can prevent chlamydia infection by not being sexually active; being in a long-term, monogamous relationship with a partner who has been tested and is negative for chlamydia; and by using condoms when you have sex.
Symptoms of chlamydia are mild and include abnormal vaginal discharge, burning sensation while peeing, lower abdominal or back pain, or low back pain. The symptoms generally appear one to three weeks after exposure.
The medical group average for the chlamydia screening measure is 53%. This means 53 out of 100 women between ages 16 and 24 who are sexually active had a chlamydia test at their medical appointment.
High rates of chlamydia screening can be a sign of strong clinical care. It’s important to know that small differences in percentages don’t necessarily reflect the quality of care you’ll receive with a certain medical group. It is more important to note the large differences between providers, and speak with your doctor if you have questions or concerns.
How we calculate the measure
We measure how well medical groups perform in making sure their sexually active, female patients between ages 16 and 24 had a test for chlamydia at their medical appointment.
This measure is evaluated annually. The current data is based on information collected from health plan billing data for dates of service between January 1 and December 31, 2017. This information is collected under the measure name Chlamydia Screening in Women.